Ulipristal
- TRADE NAMES: ella (Watson); ellaOne (HRA Pharma)
- INDICATIONS: Emergency contraception within 120 hours (5 days) of unprotected sexual intercourse or contraceptive failure
- CLASS: Progestogen antagonist
- HALF-LIFE: 32 hours
Antacids, Barbiturates, Bosentan, Carbamazepine, Clarithromycin, Conivaptan, CYP3A4 inducers, Dabigatran, Deferasirox, Digoxin, Efavirenz, Felbamate, Griseofulvin, H2-receptor antagonists, Hypericum perforatum, Itraconazole, Ketoconazole, Levonorgestrel, Nefazodone, Omeprazole, Oxcarbazepine, Pantoprazole, Phenobarbital, Phenytoin, Progestogens, Proton pump inhibitors, Rifampin, Rifapentine, Ritonavir, St John's Wort, Telithromycin, Topiramate
PREGNANCY CATEGORY: X
Please login to see the rest of this drug profile
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of ulipristal in the Taylor & Francis journal Expert Opinion on Drug Safety. (Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric